[1]
Mizuno S,Hayasaki A,Ito T,Fujii T,Iizawa Y,Kato H,Murata Y,Tanemura A,Kuriyama N,Azumi Y,Kishiwada M,Usui M,Sakurai H,Isaji S, De Novo Malignancy Following Adult-to-Adult Living Donor Liver Transplantation Focusing on Posttransplantation Lymphoproliferative Disorder. Transplantation proceedings. 2018 Nov; [PubMed PMID: 30401380]
[2]
Dharnidharka VR, Comprehensive review of post-organ transplant hematologic cancers. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2018 Mar; [PubMed PMID: 29178667]
[3]
Elserwy NA,Lotfy EE,Fouda MA,Mahmoud MI,Donia AF,Mashaly ME,Abbas MH,Abuelmagd MM,Abouelenein RK,Ismail MI,Bakr MA, Postrenal transplant malignancy: Incidence, risk factors, and prognosis. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2017 May-Jun; [PubMed PMID: 28540896]
[4]
Rosenberg AS,Ruthazer R,Paulus JK,Kent DM,Evens AM,Klein AK, Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders. Clinical lymphoma, myeloma [PubMed PMID: 27771291]
[5]
Trusson R,Serre JE,Szwarc I,Brunot V,Garrigue V,Delmas S,Kanouni T,Cartron G,Mourad G, Treatment Response and Outcomes in Post-transplantation Lymphoproliferative Disease vs Lymphoma in Immunocompetent Patients. Transplantation proceedings. 2016 Jul-Aug; [PubMed PMID: 27569924]
[6]
Luskin MR,Heil DS,Tan KS,Choi S,Stadtmauer EA,Schuster SJ,Porter DL,Vonderheide RH,Bagg A,Heitjan DF,Tsai DE,Reshef R, The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2015 Oct; [PubMed PMID: 25988622]
[7]
Gifford G,Fay K,Jabbour A,Ma DD, Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation. Internal medicine journal. 2015 May; [PubMed PMID: 25955465]
[8]
Osawa H,Uemura M,Nishimura J,Hata T,Takemasa I,Mizushima T,Yamamoto H,Doki Y,Mori M, Surgical management of perforated gastrointestinal posttransplantation lymphoproliferative disorder after heart transplantation. International surgery. 2015 Feb; [PubMed PMID: 25692442]
[9]
Choquet S,Varnous S,Deback C,Golmard JL,Leblond V, Adapted treatment of Epstein-Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2014 Apr; [PubMed PMID: 24666832]
[10]
Morton M,Coupes B,Roberts SA,Johnson SL,Klapper PE,Vallely PJ,Picton ML, Epstein-Barr virus infection in adult renal transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2014 Jul; [PubMed PMID: 24815922]
[11]
Zimmermann H,Trappe RU, EBV and posttransplantation lymphoproliferative disease: what to do? Hematology. American Society of Hematology. Education Program. 2013; [PubMed PMID: 24319169]
[12]
Trappe R,Oertel S,Leblond V,Mollee P,Sender M,Reinke P,Neuhaus R,Lehmkuhl H,Horst HA,Salles G,Morschhauser F,Jaccard A,Lamy T,Leithäuser M,Zimmermann H,Anagnostopoulos I,Raphael M,Riess H,Choquet S, Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. The Lancet. Oncology. 2012 Feb; [PubMed PMID: 22173060]
[13]
Johnson SR,Cherikh WS,Kauffman HM,Pavlakis M,Hanto DW, Retransplantation after post-transplant lymphoproliferative disorders: an OPTN/UNOS database analysis. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006 Nov; [PubMed PMID: 17049062]
[14]
Muchtar E,Kramer MR,Vidal L,Ram R,Gurion R,Rosenblat Y,Bakal I,Shpilberg O, Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience. Transplantation. 2013 Oct 15; [PubMed PMID: 23823652]